Retrospective cohort identifies risk factors and predicts postherpetic neuralgia risk in patients with herpes zoster.
New model predicts nerve pain risk following shingles outbreaks in patients.
This retrospective cohort study evaluated 846 patients with herpes zoster to predict postherpetic neuralgia risk. The XGBoost model achieved…
A new computer model predicts who will develop long-term nerve pain after shingles by spotting key risks like older age, diabetes, and sever…
FDA Approves Gabapentin Capsules (gabapentin) for Postherpetic Neuralgia and Partial Onset Seizures
FDA approves a new generic version of the drug gabapentin for nerve pain and seizures.
The FDA has approved Gabapentin Capsules, USP for the management of postherpetic neuralgia in adults and as adjunctive therapy for partial o…
FDA approves a new generic gabapentin capsule for nerve pain and seizures, offering patients another low-cost treatment option alongside exi…